StonvexLoading…
StonvexStonvexStonvexCore line items from PCYO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-02-28 | Q4 2025 2025-11-30 | Annual 2025 2025-08-31 | Q2 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $14.30M | $9.13M | $26.09M | $14.89M |
Operating Income | $4.65M | $4.38M | $7.67M | $1.73M |
Net Income | $5.67M | $4.57M | $13.11M | $7.00M |
EPS (Diluted) | $0.23 | $0.19 | $0.54 | $0.29 |
Total Assets | $166.64M | $168.07M | $162.28M | $151.74M |
Total Liabilities | $17.94M | $20.58M | $19.54M | $15.06M |
Cash & Equivalents | $4.82M | $17.14M | $21.93M | $14.39M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 24.10M | 24.09M | 24.07M | 24.07M |